Rule out all differential causes before attributing cerebral bleeding to 5-aminolevulinic acid

Finsterer, Josef; Mehri, Sounira

doi:10.1007/s00381-023-05906-3

Childs Nerv Syst

2023

DOI: 10.1007/s00381-023-05906-3

|View full text |Cite

Rule out all differential causes before attributing cerebral bleeding to 5-aminolevulinic acid

Josef Finsterer¹,

Sounira Mehri

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Utility and Safety of 5-ALA Guided Surgery in Pediatric Brain Tumors: A Systematic Review

Wang,

Yu,

Wang

et al. 2024

Cancers

View full text Add to dashboard Cite

Background: 5-Aminolevulinic acid-guided surgery for adult gliomas has been approved by the European Medicines Agency and the US Food and Drug Administration, becoming a reliable tool for improving gross total resection rates and patient outcomes. This has led several medical centers to explore the off-label use of 5-ALA in the resection of pediatric brain tumors, assessing its efficacy and safety across various tumor types. However, given the differences between children and adults, the appropriateness of 5-ALA use in pediatric populations has not yet been fully established. Methods: We collected eligible publications from Embase, Scopus, PubMed, and Proquest, ultimately selecting 27 studies. Data extraction and retrospective analysis of 249 surgical cases were conducted to determine the current efficacy and safety of 5-ALA in pediatric brain tumors. The fluorescence rate and utility stratified by several clinical features, including WHO grade, tumor classification, and tumor location, were analyzed. Results: Most studies suggest that 5-ALA can enhance tumor identification in high-grade tumors, including glioblastomas and anaplastic astrocytomas. Changes in survival or recurrence rates associated with 5-ALA-guided resection have not been reported. None of the cases reported significant postoperative complications related to the use of 5-ALA. Conclusions: 5-ALA can aid in the resection of high-grade gliomas in pediatric patients. The efficacy of 5-ALA in low-grade gliomas and other tumors may require enhancement with additional tools or modified administration protocols. The safety of 5-ALA has reached a preliminary consensus, although further randomized controlled trials and data on survival and molecular characteristics are needed.

show abstract

Utility and Safety of 5-ALA Guided Surgery in Pediatric Brain Tumors: A Systematic Review

Wang,

Yu,

Wang

et al. 2024

Cancers

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Rule out all differential causes before attributing cerebral bleeding to 5-aminolevulinic acid

Cited by 1 publication

References 5 publications

Utility and Safety of 5-ALA Guided Surgery in Pediatric Brain Tumors: A Systematic Review

Utility and Safety of 5-ALA Guided Surgery in Pediatric Brain Tumors: A Systematic Review

Contact Info

Product

Resources

About